29 June 2022 · Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
29 June 2022 · Governance should consider processes for approval; procurement and supply; prescribing and administration; monitoring; and pharmacovigilance
29 June 2022 · Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
3 February 2022 · Patient Group Directions (PGDs) may be used to supply medicines via remote consultations. Advice on clinical assessment and supply is provided.
16 November 2021 · A single Patient Group Direction (PGD) can be used to supply or administer medicines in more than one location. PGDs do not need to relate to specific premises.
16 November 2021 · This article summarises the position regarding the levying of prescription charges for medicines supplied under a PGD or an exemption to the HMR 2012.